SCHEMBL6357310

SCHEMBL6357310

O=C(Nc1ccc(Br)cc1C(=O)O)c1ccc(NC(=O)c2ccco2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIRT6 Q8N6T7 2/20 0.65
▸ RAB9A P51151 3/20 0.62
▸ SMN1; SMN2 Q16637 2/20 0.62
▸ NPC1 O15118 1/20 0.62
▸ KMT2A Q03164 8/20 0.59
▸ KDM4E B2RXH2 3/20 0.59
▸ HPGD P15428 2/20 0.59
▸ HTT P42858 2/20 0.59
▸ MAPT P10636 4/20 0.58
▸ ALDH1A1 P00352 3/20 0.58
▸ POLB P06746 2/20 0.58
▸ LMNA P02545 1/20 0.58
▸ APOBEC3G Q9HC16 1/20 0.57
▸ MEN1 O00255 6/20 0.57
▸ GAA P10253 2/20 0.56
▸ BLM P54132 1/20 0.55
▸ AKR1C4 P17516 1/20 0.55
▸ AKR1C3 P42330 1/20 0.55
▸ AKR1C2 P52895 1/20 0.55
▸ AKR1C1 Q04828 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6933566 0.91 CYP1A2 (0.61) RAB9ASMN1; SMN2NPC1KMT2AKDM4E
SCHEMBL6348632 0.89 MEN1 (0.69) SIRT6RAB9AKMT2AKDM4EMAPT
SCHEMBL6352370 0.85 MAPT (0.70) KMT2AKDM4EMAPTPOLBMEN1
SCHEMBL14075241 0.82 SERPINE1 (0.64) KMT2AMAPTMEN1AKR1C4AKR1C3
SCHEMBL17166275 0.81 AKR1C2 (0.73) KMT2AKDM4EHTTMAPTALDH1A1
SCHEMBL6359568 0.81 MAPT (0.63) RAB9ASMN1; SMN2NPC1KMT2AKDM4E
SCHEMBL16179518 0.79 SIRT6 (1.00) SIRT6RAB9AKMT2AKDM4EHPGD
SCHEMBL16179844 0.79 SIRT6 (1.00) SIRT6RAB9ASMN1; SMN2NPC1KMT2A
SCHEMBL9513479 0.79 MAPT (0.80) KMT2AHTTMAPTMEN1AKR1C4
SCHEMBL7020527 0.78 RAB9A (1.00) RAB9ASMN1; SMN2NPC1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 SIRT6 2329/4885RAB9A 3062/4885SMN1; SMN2 3015/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback